295 related articles for article (PubMed ID: 16276422)
1. A novel immunodeficiency associated with hypomorphic RAG1 mutations and CMV infection.
de Villartay JP; Lim A; Al-Mousa H; Dupont S; Déchanet-Merville J; Coumau-Gatbois E; Gougeon ML; Lemainque A; Eidenschenk C; Jouanguy E; Abel L; Casanova JL; Fischer A; Le Deist F
J Clin Invest; 2005 Nov; 115(11):3291-9. PubMed ID: 16276422
[TBL] [Abstract][Full Text] [Related]
2. A variant of SCID with specific immune responses and predominance of gamma delta T cells.
Ehl S; Schwarz K; Enders A; Duffner U; Pannicke U; Kühr J; Mascart F; Schmitt-Graeff A; Niemeyer C; Fisch P
J Clin Invest; 2005 Nov; 115(11):3140-8. PubMed ID: 16211094
[TBL] [Abstract][Full Text] [Related]
3. Diverse phenotypic and genotypic presentation of RAG1 mutations in two cases with SCID.
Karaca NE; Aksu G; Genel F; Gulez N; Can S; Aydinok Y; Aksoylar S; Karaca E; Altuglu I; Kutukculer N
Clin Exp Med; 2009 Dec; 9(4):339-42. PubMed ID: 19458910
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics of human recombination activating gene 1 mutations in 8 immunodeficiency patients with diverse phenotypes].
Yu G; Wang WJ; Liu DR; Tao ZF; Hui XY; Hou J; Sun JQ; Wang XC
Zhonghua Er Ke Za Zhi; 2018 Mar; 56(3):186-191. PubMed ID: 29518828
[No Abstract] [Full Text] [Related]
5. Phenotypical heterogeneity in RAG-deficient patients from a highly consanguineous population.
Meshaal SS; El Hawary RE; Abd Elaziz DS; Eldash A; Alkady R; Lotfy S; Mauracher AA; Opitz L; Pachlopnik Schmid J; van der Burg M; Chou J; Galal NM; Boutros JA; Geha R; Elmarsafy AM
Clin Exp Immunol; 2019 Feb; 195(2):202-212. PubMed ID: 30307608
[TBL] [Abstract][Full Text] [Related]
6. Recombinase-activating gene 1 immunodeficiency: different immunological phenotypes in three siblings.
Pasic S; Djuricic S; Ristic G; Slavkovic B
Acta Paediatr; 2009 Jun; 98(6):1062-4. PubMed ID: 19243569
[TBL] [Abstract][Full Text] [Related]
7. [Hypomorphic RAG1 mutations and CMV infection: a new phenotype of severe combined immunodeficiency].
Le Deist F; de Villartay JP; Lim A; Déchanet J; Fischer A
Med Sci (Paris); 2006 Mar; 22(3):239-40. PubMed ID: 16527199
[No Abstract] [Full Text] [Related]
8. Analysis of mutations and recombination activity in RAG-deficient patients.
Asai E; Wada T; Sakakibara Y; Toga A; Toma T; Shimizu T; Nampoothiri S; Imai K; Nonoyama S; Morio T; Muramatsu H; Kamachi Y; Ohara O; Yachie A
Clin Immunol; 2011 Feb; 138(2):172-7. PubMed ID: 21131235
[TBL] [Abstract][Full Text] [Related]
9. Co-existence of clonal expanded autologous and transplacental-acquired maternal T cells in recombination activating gene-deficient severe combined immunodeficiency.
Lev A; Simon AJ; Ben-Ari J; Takagi D; Stauber T; Trakhtenbrot L; Rosenthal E; Rechavi G; Amariglio N; Somech R
Clin Exp Immunol; 2014 Jun; 176(3):380-6. PubMed ID: 24666246
[TBL] [Abstract][Full Text] [Related]
10. Omenn's syndrome occurring in patients without mutations in recombination activating genes.
Gennery AR; Hodges E; Williams AP; Harris S; Villa A; Angus B; Cant AJ; Smith JL
Clin Immunol; 2005 Sep; 116(3):246-56. PubMed ID: 15964782
[TBL] [Abstract][Full Text] [Related]
11. Omenn syndrome--review of several phenotypes of Omenn syndrome and RAG1/RAG2 mutations in Japan.
Kato M; Kimura H; Seki M; Shimada A; Hayashi Y; Morio T; Kumaki S; Ishida Y; Kamachi Y; Yachie A
Allergol Int; 2006 Jun; 55(2):115-9. PubMed ID: 17075247
[TBL] [Abstract][Full Text] [Related]
12. Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.
Tabori U; Mark Z; Amariglio N; Etzioni A; Golan H; Biloray B; Toren A; Rechavi G; Dalal I
Clin Genet; 2004 Apr; 65(4):322-6. PubMed ID: 15025726
[TBL] [Abstract][Full Text] [Related]
13. A Large Cohort of RAG1/2-Deficient SCID Patients-Clinical, Immunological, and Prognostic Analysis.
Greenberg-Kushnir N; Lee YN; Simon AJ; Lev A; Marcus N; Abuzaitoun O; Somech R; Stauber T
J Clin Immunol; 2020 Jan; 40(1):211-222. PubMed ID: 31838659
[TBL] [Abstract][Full Text] [Related]
14. Clinical, immunologic, and genetic characteristics of RAG mutations in 15 Chinese patients with SCID and Omenn syndrome.
Bai X; Liu J; Zhang Z; Liu C; Zhang Y; Tang W; Dai R; Wu J; Tang X; Zhang Y; Ding Y; Jiang L; Zhao X
Immunol Res; 2016 Apr; 64(2):497-507. PubMed ID: 26476733
[TBL] [Abstract][Full Text] [Related]
15. [Omenn Syndrome and DNA recombination defects].
Yachie A
Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(3):179-189. PubMed ID: 28747605
[TBL] [Abstract][Full Text] [Related]
16. Leaky RAG Deficiency in Adult Patients with Impaired Antibody Production against Bacterial Polysaccharide Antigens.
Geier CB; Piller A; Linder A; Sauerwein KM; Eibl MM; Wolf HM
PLoS One; 2015; 10(7):e0133220. PubMed ID: 26186701
[TBL] [Abstract][Full Text] [Related]
17. Omenn syndrome: a disorder of Rag1 and Rag2 genes.
Villa A; Santagata S; Bozzi F; Imberti L; Notarangelo LD
J Clin Immunol; 1999 Mar; 19(2):87-97. PubMed ID: 10226883
[TBL] [Abstract][Full Text] [Related]
18. Oligoclonal expansion of T lymphocytes with multiple second-site mutations leads to Omenn syndrome in a patient with RAG1-deficient severe combined immunodeficiency.
Wada T; Toma T; Okamoto H; Kasahara Y; Koizumi S; Agematsu K; Kimura H; Shimada A; Hayashi Y; Kato M; Yachie A
Blood; 2005 Sep; 106(6):2099-101. PubMed ID: 15845893
[TBL] [Abstract][Full Text] [Related]
19. Clinical Manifestations, Mutational Analysis, and Immunological Phenotype in Patients with RAG1/2 Mutations: First Cases Series from Mexico and Description of Two Novel Mutations.
Lugo-Reyes SO; Pastor N; González-Serrano E; Yamazaki-Nakashimada MA; Scheffler-Mendoza S; Berron-Ruiz L; Wakida G; Nuñez-Nuñez ME; Macias-Robles AP; Staines-Boone AT; Venegas-Montoya E; Alaez-Verson C; Molina-Garay C; Flores-Lagunes LL; Carrillo-Sanchez K; Niemela J; Rosenzweig SD; Gaytan P; Yañez JA; Martinez-Duncker I; Notarangelo LD; Espinosa-Padilla S; Cruz-Munoz ME
J Clin Immunol; 2021 Aug; 41(6):1291-1302. PubMed ID: 33954879
[TBL] [Abstract][Full Text] [Related]
20. The immunophenotypic and immunogenotypic B-cell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins.
Noordzij JG; de Bruin-Versteeg S; Verkaik NS; Vossen JM; de Groot R; Bernatowska E; Langerak AW; van Gent DC; van Dongen JJ
Blood; 2002 Sep; 100(6):2145-52. PubMed ID: 12200379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
